Preinbergs, Julia K.
Ström, Jakob O.
Theodorsson, Elvar
Ingberg, Edvin
Funding for this research was provided by:
Region Östergötland
Linköpings Universitet
Örebro Universitet
Linköping University
Article History
Received: 6 April 2023
Accepted: 30 August 2023
First Online: 25 September 2023
Competing interests
: Jakob O Ström received advisory board fees from Bayer Pharmaceuticals in 2016 and 2019, but the advisory boards were not in any way related to the subject of the current paper. Julia K Preinbergs, Edvin Ingberg and Elvar Theodorsson declare no potential conflict of interest.